NSE
Alembic LimitedALEMBICLTD
Alembic Limited is a pharmaceutical company based in India, known for its focus on generic drugs and APIs.
| Key products | Generic drugs and Active Pharmaceutical Ingredients (APIs) |
|---|---|
| Geography | India |
| Competitors | Dr Reddy's Laboratories, Cipla |
AI-generated overview — verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
—
Competitive landscape — the read
vs most-traded names| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | MTNL | +₹41.3 Cr | 331 | — | — | — | — |
| 2 | ATALREAL | +₹7.4 Cr | 363 | — | — | — | — |
| 3 | GATECH | +₹0.4 Cr | 298 | — | — | — | — |
| 4 | ALEMBICLTDThis | — | — | — | — | +3 | 6 |
| 5 | IRMENERGY | −₹2.2 Cr | 356 | — | — | — | — |
| 6 | QUADFUTURE | −₹9 Cr | 571 | — | — | — | — |
| 7 | MOBIKWIK | −₹150.9 Cr | 975 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Strengths
- • Strong presence in the Indian generics market
- • Diversified portfolio of products with a focus on niche areas
- • Established manufacturing capabilities
- • Growing presence in international markets
Weaknesses
- • Dependence on a few key products and customers
- • High competition from established players like Dr Reddy's Laboratories
- • Regulatory challenges in the Indian market
- • Limited presence in innovative pharmaceuticals
Opportunities
- • Increasing demand for generic drugs globally
- • Growing need for APIs in emerging markets
- • Potential for partnerships with international companies
- • Expansion into new product categories
Threats
- • Compliance risks due to changing regulatory environments
- • Risk of patent expirations and loss of market share
- • Intense competition from low-cost producers
- • Volatility in raw material prices
AI-generated from our data — verify before relying on it.
Timeline — ALEMBICLTD day by day
- 2026-06-11FilingAlembic Limited has informed the Exchange about Copy of Newspaper PublicationCompliance
- 2026-06-09FilingAlembic Limited has informed the Exchange about Copy of Newspaper PublicationCompliance
- 2026-06-09NewsAlembic Limited fixes August 4 as record date for FY26 dividendscanx.trade
- 2026-05-19NewsAlembic Limited Recommends Dividend for the Year Ended March 31, 2026marketscreener.com
- 2026-04-21NewsAlembic Limited Launches Second 100-Day 'Saksham Niveshak' Campaign for Dividend Claimsscanx.trade
- 2022-03-24NewsAlembic Pharmaceuticals Ltd. Share Price Today | Alembic Pharma Live NSE/BSEValue Research
- 2022-01-07NewsAlembic Pharmaceuticals Share Price Today - Live NSE/BSEICICI Direct
- 2017-07-19NewsALEMBICLTD Stock Price and Chart — NSE:ALEMBICLTDTradingView
Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.
Filings that matter
- 1
- 1
No bulk/block deals for ALEMBICLTD in this window.
News & chatter on ALEMBICLTD
RSS News
6▲scanx.trade · 9/6/2026
▲marketscreener.com · 19/5/2026
▲scanx.trade · 21/4/2026
Value Research · 25/3/2022
ICICI Direct · 8/1/2022
TradingView · 20/7/2017
Google News RSS — links open the source.
The Dispatch
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.